tradmap

INCY Incyte

$128.00 -0.68%

Updated

S&P 500 Companies

Held by SPYVOOIVV

Industrials · Services-Commercial Physical & Biological Research

Incyte (INCY) is a industrials company in the Services-Commercial Physical & Biological Research industry, with a market capitalization of $25.6 billion. Shares last traded at $128.00, 3.5% below their 52-week high. Over the past year the stock is up 47.2%. INCY trades at a price-to-earnings ratio of 17.86, below the Services-Commercial Physical & Biological Research median of 33.22. Net profit margin is 26.7%, above the peer median of 8.3%. Revenue grew 21.2% year over year.

Market Cap
$25.6B
Shares Out
199.8M
EPS (TTM)
$10.06
P/E Ratio
12.72
P/S Ratio
4.77
P/B Ratio
4.55
Dividend / Share
Dividend Yield
52-Week High
$132.59
52-Week Low
$81.09
Volume
37,731
Avg Vol (3m)
86,189.571

Performance

1W
+0.22%
1M
+6.86%
3M
+26.41%
6M
+31.51%
YTD
+26.14%
1Y
+47.17%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
59.28
SMA (50)
$120.45
SMA (200)
$104.62
Price vs SMA50
+6.27%
Price vs SMA200
+22.35%
ATR (14)
$3.31

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$5.4B
Net Income
$1.4B
Gross Margin
92.5%
Operating Margin
30.0%
Net Margin
26.7%
Return on Equity
25.5%
Return on Assets
19.5%
Current Ratio
3.68
Debt / Equity
3.40
Revenue Growth (YoY)
+21.2%

Latest reported annual period ending 2026-03-31 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $1.47 2026-04-28
FY 2025 $6.41 2026-02-10
Q3 2025 $4.95 2025-10-28
Q2 2025 $2.84 2025-07-29
Q1 2026 $0.80 2026-04-28
FY 2025 $0.15 2026-02-10

Full earnings history →

Services-Commercial Physical & Biological Research peers

INCY vs 14 industry peers (Services-Commercial Physical & Biological Research), by market cap. Updated

P/E vs peers
17.86 / 33.22 med
-46% discount
P/S vs peers
4.77 / 4.14 med
+15% premium
Net margin vs peers
26.7% / 8.3% med
above median
1–14 of 14
IQVIQVIA$45.3B32.742.738.3%+2.95%
INCYIncyte$25.6B17.864.7726.7%-0.68%
MEDPMedpace Holdings, Inc.$16.6B33.705.9517.7%+0.09%
CRLCharles River Laboratories$14.0B-58.723.50-6.0%+0.54%
ABSIAbsci Corp$1.5B-12.46332.71-0.06%
OABIOmniAb, Inc.$689M-15.57-5.77%
NRCNrc Health$470M40.513.368.3%+6.23%
MXCTMAXCYTE, INC.$131M-3.66-1.17%
BIAFbioAffinity Technologies, Inc.$100M-6.60+22.48%
ONMDOneMedNet Corp$35M-4.15+4.13%
ISPCiSpecimen Inc.$4M-0.34+4.70%
IBACRIB Acquisition Corp.$580955-1.45+0.87%
ICLRIcon Plc2.1%+2.36%
BIAFWbioAffinity Technologies, Inc.+80.18%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.